Brief: Lucira Health Inc Says On March 8, Provided Notice Of Termination Of Patent License Agreement Dated July 15, 2020, By And Between Co And Eiken Chemical
March 14 (Reuters) - Lucira Health Inc LHDX.O :
* LUCIRA HEALTH INC - ON MARCH 8, PROVIDED NOTICE OF
TERMINATION
OF PATENT LICENSE AGREEMENT DATED JULY 15, 2020, BY AND BETWEEN
CO AND EIKEN CHEMICAL
* LUCIRA HEALTH INC - TERMINATION OF AGREEMENT WILL BE
EFFECTIVE
MAY 12, 2022
* LUCIRA HEALTH INC - FOLLOWING TERMINATION OF AGREEMENT,
WILL NOT
BE REQUIRED TO MAKE ANY FUTURE PAYMENTS UNDER AGREEMENT
Source text for Eikon: ID:
Further company coverage: LHDX.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Lucira Health
See all newsBrief: Lucira Health Inc Filed Its Amended Chapter 11 Plan Of Liquidation With Bankruptcy Court
Brief: Lucira Health Files Proposed Chapter 11 Plan Of Liquidation
Brief: Bankruptcy Court Approves Lucira Health Assets Sale To Pfizer
Brief: Lucira Health Inc Says On April 6, 2023 Co Held Auction Relating To Disposition Of All Or Substantially All Of Company's Assets
Brief: Lucira Health Announces U.S. Launch Of First & Only At-Home Combination Covid-19 & Flu Test Amidst Sale Process